We are live on
!
Find out more
HP
HealthInvest Partners Portfolio holdings
AUM
$372M
1-Year Est. Return
59.89%
This Fund
S&P 500
This Quarter
Est. Return
+10.87%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
–
Cap. Flow
+$99.1M
Cap. Flow
% of AUM
98.57%
Top 10 Holdings %
Top 10 Hldgs %
83.53%
Holding
18
New
18
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$11.2M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$11M |
| 3 |
Charles River Laboratories
CRL
|
+$11M |
| 4 |
Myriad Genetics
MYGN
|
+$9.57M |
| 5 |
AIQ
Alliance Healthcare Services
AIQ
|
+$7.35M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.82% |
Similar funds
KP
AWA
TCM
SAAM
SC
PAA
PC
BOCH
HealthInvest Partners's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for HealthInvest Partners, which disclosed 18 positions worth $101M. Its ten largest holdings account for 84% of the portfolio.
Its largest position is Medtronic: 197,900 shares worth $11.4M.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets.
- HealthInvest Partners's largest Q4 2013 buy was Medtronic: 197,900 shares worth $11.4M.
- HealthInvest Partners's ten largest holdings make up 84% of its $101M portfolio in Q4 2013.
- HealthInvest Partners disclosed 18 positions in Q4 2013, its first 13F filing on record.
Based on HealthInvest Partners's 13F filing for Q4 2013, filed 5 Feb 2014.